Approval · Notice of Compliance 37965 · 2026
SATIVEX: Notice of Compliance 37965
Issued July 22, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37965
- Date
- July 22, 2026
- Company
- Cnx Therapeutics LimitedLondon, United Kingdom
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Change in product ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SATIVEX | 02266121 | Marketed |
Medicinal ingredients
- DELTA-9-TETRAHYDROCANNABINOL 2.7 MG per ACT
- CANNABIDIOL 2.5 MG per ACT